Science

Sucampo Pharmaceuticals' stock surges after Mallinckrodt buyout deal

Sucampo Pharmaceuticals' stock surges after Mallinckrodt buyout deal”

(NASDAQ:SCMP) during the first quarter, Holdings Channel reports. More interesting news about Sucampo Pharmaceuticals, Inc.

Several other large investors have also modified their holdings of SCMP. Finally, Aperio Group LLC acquired a new stake in Sucampo Pharmaceuticals in the 3rd quarter valued at $137,000. About 13.07M shares traded or 1022.29% up from the average. Swiss National Bank now owns 43,859 shares of the biopharmaceutical company's stock valued at $461,000 after purchasing an additional 8,000 shares during the period. Cadence Capital Management LLC raised its position in shares of Sucampo Pharmaceuticals by 33.4% in the fourth quarter. Nine Chapters Capital Management LLC acquired a new position in shares of Sucampo Pharmaceuticals during the third quarter valued at $127,000. Eqis Capital Management Inc. now owns 40,651 shares of the biopharmaceutical company's stock valued at $480,000 after purchasing an additional 9,012 shares during the period.

Goldman Sachs Group Inc increased Sucampo Pharmaceuticals Inc (SCMP) stake by 550.7% reported in 2017Q3 SEC filing. (NASDAQ:SCMP). Ny State Teachers Retirement Sys holds 0% in Sucampo Pharmaceuticals, Inc. The company has a current ratio of 5.11, a quick ratio of 4.46 and a debt-to-equity ratio of 7.37. The company has a market cap of $790.48, a price-to-earnings ratio of -5.17, a PEG ratio of 5.04 and a beta of 1.47. Sucampo Pharmaceuticals has a 12-month low of $9.30 and a 12-month high of $17.70.

More news: Steward Partners Investment Advisory LLC Invests $1.22 Million in General Mills, Inc

Sucampo Pharmaceuticals (NASDAQ:SCMP) last announced its quarterly earnings data on Wednesday, November 1st. The biopharmaceutical company reported $0.23 earnings per share for the quarter, missing the consensus estimate of $0.28 by $0.05. Sucampo Pharmaceuticals had a return on equity of 126.04% and a net margin of 16.92%. The business had revenue of $61.27 million for the quarter, compared to the consensus estimate of $58.05 million. After $0.27 actual earnings per share reported by Sucampo Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 25.93 % EPS growth. Kiener Peter A sold $825,000 worth of stock. On the other side it is a negative indicator for Investor portfolio value - when the price of a stock Investor owns moves down in value. Sucampo Pharma had 39 analyst reports since August 6, 2015 according to SRatingsIntel. BidaskClub raised Sucampo Pharmaceuticals from a "hold" rating to a "buy" rating in a research report on Tuesday, December 5th. (NASDAQ:SCMP) hit a new 52-week high and has $18.64 target or 4.00 % above today's $17.93 share price. The firm has "Buy" rating given on Tuesday, November 15 by Maxim Group. (SCMP)'s current distance from 20-Day Simple Moving Average is 15.49% and standing 41.47% away from 50-Day Simple Moving Average while traded up 54.00% from 200-Day Simple Moving Average. Sucampo Pharmaceuticals Inc now has $788.97 million valuation. "(SCMP)" was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally stolen and republished in violation of USA & worldwide trademark & copyright laws. The legal version of this story can be accessed at https://weekherald.com/2017/12/26/sucampo-pharmaceuticals-scmp-downgraded-by-b-riley.html. Lazard Asset Mgmt Limited Com has invested 0% in Sucampo Pharmaceuticals, Inc. The Company is focused on the development and commercialization of pharmaceutical products.

Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing medicines that meet unmet medical needs, primarily in gastroenterology, ophthalmology, and oncology-related disorders in the United States, Japan, Switzerland, and internationally. The companyÂ's marketed product includes AMITIZA, a ClC-2 chloride channel activator for the treatment of chronic idiopathic constipation (CIC) in adults, irritable bowel syndrome with constipation in adult women (IBS-C), and opioid-induced constipation (OIC) in patients with chronic non-cancer related pain; and RESCULA (unoprostone isopropyl), a big potassium channel activator for the treatment of glaucoma and ocular hypertension. (NASDAQ:SCMP). 2.47 million are held by Lsv Asset.



Like this

loading...
loading...

Latest


27 December 2017
British Columbia Investment Management Corp Increases Holding in Philip Morris Intl INC (PM)
Philip Morris International Inc now has $161.36 billion valuation. (NYSEAMERICAN:NES) has 0.00% since December 26, 2016 and is. Loring Wolcott & Coolidge Fiduciary Llp Ma holds 1.08% in Philip Morris International Inc. (NYSE:PM) on Wednesday, August 30.

27 December 2017
BlackRock, Inc. (BLK) EPS Estimated At $5.93
Linden Advisors Lp decreased its stake in 51Job Inc (JOBS) by 84.27% based on its latest 2017Q3 regulatory filing with the SEC. Its up 0.10, from 1.28 in 2017Q2. 213.38 million shares or 1.82% more from 209.56 million shares in 2017Q2 were reported.

26 December 2017
Brock Lesnar Confirmed For Next Week's WWE Raw
Elias says he's going to perform no matter how often they want to chant that and he's going to perform without interruptions. Elias says he never thought of it that way but it is Christmas and maybe Cena is right, maybe he is the jerk.

26 December 2017
Panic as police scramble to 'shots fired' in Oxford Street
People at the scene reported on social media that shoppers were evacuated from the store and police and an ambulance had arrived. Photos from the scene show smashed window to the House of Fraser building, in front of a display for Swarovski Crystals.

26 December 2017
CSX Corporation (CSX) Analysts See $0.56 EPS
It increased, as 44 investors sold CERN shares while 209 reduced holdings. 128 funds opened positions while 644 raised stakes. Market capitalization is calculated by multiplying a company's shares outstanding by the current market price of one share.

26 December 2017
Extreme cold temperatures to continue across Saskatchewan
Southern Ontario was largely spared from the extreme cold, save for parts of southwestern Ontario surrounding the Georgian Bay. Environment Canada is forecasting a "multi-day episode of very cold wind chills" starting Monday for the Edmonton-St.

26 December 2017
Mariah Carey Returns As Headliner For Time Square New Year's Eve Bash
Carey's forthcoming New Year's Eve performance will top an already merry holiday season for the star. There's every reason to think that this year's performance will end differently for Carey.

26 December 2017
Navalny Supporters Rally in Russian Cities to Support Presidential Nomination
While Putin is all but certain to win an easy victory, the Kremlin wants his performance to be as strong as possible. Navalny is widely seen as the only politician who stands any chance of challenging Putin.

26 December 2017
Analysts Give Royal Dutch Shell (RDSB) a GBX 2850 Price Target
Goldman Sachs maintained the shares of RDSB in report on Friday, November 4 with "Conviction Buy" rating . The stock of Royal Dutch Shell plc (NYSE:RDS.A) has "Buy" rating given on Wednesday, June 8 by Evercore.

26 December 2017
Trump administration to roll back offshore drilling safety measures
Industry officials argue the safety rules are too broad, and the Trump administration appears to agree. BSEE sent the proposal to the White House Dec. 8, The Journal said.